AIM ImmunoTech (AIM) Non Operating Interest Expenses (2011 - 2026)
AIM ImmunoTech (AIM) reported Non Operating Interest Expenses of $295,000 for Q2 2026, up 98.0% from $149,000 a year earlier but down 3.0% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Non Operating Interest Expenses (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AIM ImmunoTech's Non Operating Interest Expenses came in at $1.14 million, up 87.5% year-over-year; for FY2025, it was $812,000, up 38.8% from FY2024.
- Non Operating Interest Expenses has a five-year compound annual growth rate of 3.9% (FY2020 to FY2025).
- By year, Non Operating Interest Expenses came in at $585,000 in FY2024 and $67,000 in FY2021 (-90.0%).
- Five-year quarterly Non Operating Interest Expenses spans a low of $72,000 in Q1 2024 and a high of $391,000 in Q4 2025.
- Year over year, Non Operating Interest Expenses has now increased in each of the last three quarters, with growth averaging 78.0% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $304,000 (Q1 2026), $391,000 (Q4 2025) and $148,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 295,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 295,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 391,000.00 |
| Sep 30, 2025 | 148,000.00 |
| Jun 30, 2025 | 149,000.00 |
| Mar 31, 2025 | 124,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | 179,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Mar 31, 2021 | 50,000.00 |
| Dec 31, 2020 | 55,000.00 |
| Sep 30, 2020 | 51,000.00 |
| Jun 30, 2020 | 249,000.00 |
| Mar 31, 2020 | 322,000.00 |
| Dec 31, 2019 | -110,000.00 |
| Sep 30, 2019 | 193,000.00 |
| Jun 30, 2019 | 99,000.00 |
| Mar 31, 2019 | 246,000.00 |
API Access
AIM ImmunoTech Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();